135 related articles for article (PubMed ID: 2430577)
1. [Physico-chemical and biological properties of a new plasma substitute based on hydroxyethylated starch].
Kudriashov LI; Dombrovskiĭ VA; Alekseeva GS; Iarovaia SM; Chlenov MA
Bioorg Khim; 1986 Jun; 12(6):812-8. PubMed ID: 2430577
[TBL] [Abstract][Full Text] [Related]
2. [Physicochemical and biological properties of hydroxyethyl starch].
Polushina TV; Prostakova TM; Andrianova IuI; Luk'ianova NA; Kuznetsova VM
Probl Gematol Pereliv Krovi; 1980 Sep; 25(9):12-5. PubMed ID: 6158737
[No Abstract] [Full Text] [Related]
3. Evaluation of modern plasma expanders and blood substitutes.
Rudowski WJ
Br J Hosp Med; 1980; 23(4):389-99. PubMed ID: 6155961
[No Abstract] [Full Text] [Related]
4. [Determination of the molecular weight of microbial polysaccharides using high performance exclusion chromatography].
Chlenov MA; Iarovaia SM; Alekseeva GS; Kudriashov LI; Titova EV
Prikl Biokhim Mikrobiol; 1987; 23(4):515-21. PubMed ID: 2443909
[TBL] [Abstract][Full Text] [Related]
5. Influence of intravenous infusions of hydroxyethylstarch (HES) (MW 40,000 and 450,000) on the blood flow properties of healthy volunteers.
Ehrly AM; Landgraf H
Angiology; 1985 Jan; 36(1):41-4. PubMed ID: 2411169
[TBL] [Abstract][Full Text] [Related]
6. An experimental study on the effect of plasma expanders on blood coagulability.
Narita T; Matsumoto I; Kumazawa T; Ikezono E
Bull Tokyo Med Dent Univ; 1979 Mar; 26(1):25-32. PubMed ID: 85502
[TBL] [Abstract][Full Text] [Related]
7. Hydroxyethylstarch and renal function in kidney transplant recipients.
Holzheimer R
Lancet; 1997 Mar; 349(9055):883-4; author reply 884. PubMed ID: 9121292
[No Abstract] [Full Text] [Related]
8. Hydroxyethylstarch and renal function in kidney transplant recipients.
Coronel B; Mercatello A; Martin X; Lefrancois N
Lancet; 1997 Mar; 349(9055):884; author reply 884. PubMed ID: 9121293
[No Abstract] [Full Text] [Related]
9. Energy of activation of hetastarch in a limited range of thermal exposition.
Concettoni C; Moretti V; Piantelli F; Re L; Rossini L
Acta Physiol Hung; 1990; 75 Suppl():59-60. PubMed ID: 1695420
[No Abstract] [Full Text] [Related]
10. [The effects of 500 ml 10% hydroxyethyl starch 200/0.5 and 10% dextran 40 on blood volume, colloid osmotic pressure and renal function in human volunteers (author's transl)].
Köhler H; Zschiedrich H; Clasen R; Linfante A; Gamm H
Anaesthesist; 1982 Feb; 31(2):61-7. PubMed ID: 6177264
[TBL] [Abstract][Full Text] [Related]
11. Synthetic plasma volume expanders--their pharmacology, safety and clinical efficacy.
Mishler JM
Clin Haematol; 1984 Feb; 13(1):75-92. PubMed ID: 6202449
[No Abstract] [Full Text] [Related]
12. Determination of sodium caprylate in plasma volume expanders by gas chromatography.
Lee YC; Johnson JH
J Chromatogr; 1986 Jun; 361():279-84. PubMed ID: 2426293
[TBL] [Abstract][Full Text] [Related]
13. [Comparative study of the modification of blood, blood coagulation, cardiovascular circulation by 3% modified, fluid gelatins and 6% low-molecular weight hydroxyethyl starch].
Hopf HB; Siepmann HP
Infusionsther Klin Ernahr; 1987 Apr; 14 Suppl 2():31-5. PubMed ID: 2439456
[TBL] [Abstract][Full Text] [Related]
14. [Blood volume replacement using hydroxyethyl starch or Dextran 60].
Hölscher B
Infusionstherapie (1973); 1974 Apr; 1(4):281-5. PubMed ID: 4142945
[No Abstract] [Full Text] [Related]
15. [The influence of hydroxyethyl starch on blood clotting (author's transl)].
Peter K; Gander HP; Lutz H; Nold W; Stosiek U
Anaesthesist; 1975 May; 24(5):219-24. PubMed ID: 56903
[TBL] [Abstract][Full Text] [Related]
16. Hydroxyethylstarch 200 and 240 differently affect aortic distensibility but not viscosity and blood pressure upon acute isovolumic hemodilution.
Caron A; Hacquard M; Audibert G; Cauchois G; Vigneron C; Stoltz JF; Longrois D; Menu P
Clin Hemorheol Microcirc; 2006; 35(4):447-58. PubMed ID: 17148843
[TBL] [Abstract][Full Text] [Related]
17. [Advantages of application of hydroxyethylstarch of the III generation during the operations with epidural anesthesia].
Potapov OL
Klin Khir; 2010 May; (5):47-50. PubMed ID: 20623980
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of vasoactive agents by perfluorochemical emulsion.
Saeed M; Hartmann A; Bing RJ
Life Sci; 1987 May; 40(20):1971-9. PubMed ID: 2437426
[TBL] [Abstract][Full Text] [Related]
19. Clinical pharmacology of hydroxyethyl starches.
Mishler JM
Rev Fr Transfus Immunohematol; 1980; 23(3):283-98. PubMed ID: 6157397
[No Abstract] [Full Text] [Related]
20. The cryoprotective properties of hydroxyethyl starch investigated by means of differential thermal analysis.
Körber C; Scheiwe MW
Cryobiology; 1980 Feb; 17(1):54-65. PubMed ID: 6156052
[No Abstract] [Full Text] [Related]
[Next] [New Search]
